Company Plans to Provide Update on Key Regulatory Milestones
SEATTLE, Sept. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTICD; and MTA: CTIC) announced today that it will host an investor day in Milan, Italy on October 3, 2008. The investor day will provide an update from executive management on key strategic initiatives and regulatory milestones for the Company. The meeting will be an invitation-only event. A webcast and live teleconference of the event will be available to all investors. Additional event details will provided in the near future.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed
to developing an integrated portfolio of oncology products aimed at making
cancer more treatable. For additional information, please visit
T : 206.272.4347
F : 206.272.4434
|SOURCE Cell Therapeutics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved